Bioanalytical Systems (BASI) Posts Q4 GAAP Loss of 32c/Share
Tweet
Share
E-mailGet Alerts BASI Hot Sheet
Price: $16.44 --0%
Financial Fact:
Total operating expenses: 1.54M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 1.54M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bioanalytical Systems (NASDAQ: BASI) reported Q4 EPS of ($0.32), which may not compare with the analyst estimate of ($0.03). Revenue for the quarter came in at $6.54 million versus the consensus estimate of $7.07 million.
EBITDAR, a non-GAAP measure, improved from $205,000 last year to $891,000 in the recent quarter.
For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.
EBITDAR, a non-GAAP measure, improved from $205,000 last year to $891,000 in the recent quarter.
For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Axos Financial (AX) PT Raised to $120 at Benchmark
- Omega Flex (OFLX) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
